TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12963899

Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 37

Group type: COMPARATOR
Intervention: Tretinoin cream 0.025%
Number of subjects: 37

Group type: COMPARATOR
Intervention: Tretinoin microsphere gel 0.1%
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Combination of adapalene gel 0.1% with various antimicrobial agents
Number of subjects: 37
Study: 11401938

Group type: EXPERIMENTAL
Intervention: Thin-strut stent (strut thickness of 50 microm)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Thick-strut stent (strut thickness of 140 microm)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Both stent types
Number of subjects: 651
Study: 9234040

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 24-hr patch
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 16-hr patch
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 24-hr patch plus gum
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Double 24-hr patch
Number of subjects: 18

Group type: COMPARATOR
Intervention: No nicotine replacement
Number of subjects: 18
Study: 7961259

Group type: EXPERIMENTAL
Intervention: Inspiratory flow-resistive loading (L2: 125 cmH2O.l‐1.s)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inspiratory flow-resistive loading (L3: 250 cmH2O.l‐1.s)
Number of subjects: 10
Study: 3475725

Group type: EXPERIMENTAL
Intervention: Intra-amniotic 1.5 mg 15(S) 15 methyl PGF2 alpha (PGF2 alpha)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Indomethacin 25 mg and 50 mg orally three and one hour before PGF2 alpha
Number of subjects: 20
Study: 2076744

Group type: EXPERIMENTAL
Intervention: Activated charcoal suspension (5 g as 200 ml)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Activated charcoal tablets (40 of 125 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Activated charcoal capsules (25 of 200 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control treatment (suspension medium without AC)
Number of subjects: 8
Study: 1215547

Group type: EXPERIMENTAL
Intervention: 15(S)15‐methyl‐PGF2alpha (400 mug extra‐amniotically one hour prior to vacuum aspiration)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg X 4 over 24 hours)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg X 6 over 36 hours)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (11 women)
Number of subjects: 39
Study: 31107276

Group type: EXPERIMENTAL
Intervention: Maintained PEEP (n = 16)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Zero PEEP (n = 14)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 27899531

Group type: EXPERIMENTAL
Intervention: RT disease management program
Number of subjects: 428

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 428
Study: 26978624

Group type: EXPERIMENTAL
Intervention: Advanced techniques including minimally invasive surgical sanitation of infected fracture zone followed by differentiated tactics of consistent and gradual minimally invasive functionally stable osteosynthesis with modern APS and implants on a background of conservative therapy consisting of Cycloferon.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional scheme using only external fixation devices or metal obsolete models.
Number of subjects: 60
Study: 23888318

Group type: EXPERIMENTAL
Intervention: Fish oil (2 g/day)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: High-oleic sunflower oil (8 g/day)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Fish oil (2 g/day) and High-oleic sunflower oil (8 g/day)
Number of subjects: 98
Study: 21349225

Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 19216890

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 17383095

Group type: EXPERIMENTAL
Intervention: Electrical nerve stimulation (ENS)
Number of subjects: 1227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1227
Study: 15536111

Group type: EXPERIMENTAL
Intervention: DHEA 50 mg/d for 6 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 11238151

Group type: EXPERIMENTAL
Intervention: 0.97 mg/kg amphotericin B by continuous infusion over 24 hours
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.95 mg/kg amphotericin B by rapid infusion over four hours
Number of subjects: 80
Study: 9768384

Group type: EXPERIMENTAL
Intervention: Educational program based on Bandura's self-efficacy theory and Freire's empowerment pedagogy
Number of subjects: 88
Study: 7837144

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Systemic lupus erythematosus (SLE)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Cancer
Number of subjects: 91

Group type: COMPARATOR
Intervention: Pneumonia
Number of subjects: 91

Group type: COMPARATOR
Intervention: Congestive heart failure
Number of subjects: 91

Group type: COMPARATOR
Intervention: Tuberculous pleurisy
Number of subjects: 91
Study: 3417935

Group type: EXPERIMENTAL
Intervention: 2-day video-based workshop for teaching the conversational model of psychotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 30543461

Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg thrice daily for 14 days)
Number of subjects: 83
Study: 27484978

Group type: EXPERIMENTAL
Intervention: Aerobic exercise plus pharmacotherapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Only pharmacotherapy
Number of subjects: 26
Study: 26033708

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy with paclitaxel plus gemcitabine (PG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study: 23587015

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with sertraline
Number of subjects: 200
Study: 22007522

Group type: EXPERIMENTAL
Intervention: Lisinopril/hydrochlorothiazide combined tablets (high, medium, low doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated administration of lisinopril/hydrochlorothiazide combined tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lisinopril (test medication)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (test medication)
Number of subjects: 0
Study: 18446103

Group type: EXPERIMENTAL
Intervention: Nasogastric feeding (n = 27)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Postpyloric feeding (n = 17)
Number of subjects: 44
Study: 16483884

Group type: EXPERIMENTAL
Intervention: Functional oil (Phytosterols mixed with medium-chain triglycerides and high-oleic canola oil)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Olive oil (Control)
Number of subjects: 23
Study: 14739723

Group type: EXPERIMENTAL
Intervention: Unipolar and bipolar electrograms (61 PVs)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Bipolar electrograms only (53 PVs)
Number of subjects: 44
Study: 10885423

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure (300 microg x m(‐3) for 1 h)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sputum induction procedure
Number of subjects: 15
Study: 8620790

Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine 20 mg
Number of subjects: 20
Study: 1622645

Group type: COMPARATOR
Intervention: Radiotherapy only
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Radiotherapy and adjuvant tamoxifen for one year
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen without radiotherapy
Number of subjects: 719
Study: 6381432

Group type: EXPERIMENTAL
Intervention: Bromodeoxyuridine (BUdR) with conventional fractionated radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iododeoxyuridine (IUdR) with conventional fractionated radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusions of BUdR and IUdR
Number of subjects: 0
Study: 30054160

Group type: EXPERIMENTAL
Intervention: 11vPHiD-CV
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: 12vPHiD-CV
Number of subjects: 951

Group type: COMPARATOR
Intervention: PHiD-CV
Number of subjects: 951

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 951
Study: 29695500

Group type: EXPERIMENTAL
Intervention: Individually tailored rituximab regimen (500 mg infusion at randomisation, reinfusion based on CD19+B lymphocytes or ANCA levels)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Fixed-schedule rituximab regimen (500 mg infusion on days 0 and 14, then at 6, 12, and 18 months)
Number of subjects: 162
Study: 29471771

Group type: EXPERIMENTAL
Intervention: 6-week self-management program
Number of subjects: 46

Group type: COMPARATOR
Intervention: Wait-list control group (pamphlets on exercise and joint care)
Number of subjects: 46
Study: 24118023

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg day(-1) for 4 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg day(-1) for 4 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg day(-1) for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy control group (no treatment)
Number of subjects: 60
Study: 22928363

Group type: EXPERIMENTAL
Intervention: Low-caloric diet (1200‐1500 kcal/day) with modified fatty acids pool (PUFA n‐3/n‐6 ratio 1:5)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (PUFA n‐3/n‐6 ratio 1:10)
Number of subjects: 23
Study: 20521025

Group type: EXPERIMENTAL
Intervention: SIGH (periodical high pressure breaths)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: BIPAP (biphasic positive pressure ventilation)
Number of subjects: 21

Group type: COMPARATOR
Intervention: CPAP(basal)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CPAP(final)
Number of subjects: 21
Study: 18521686

Group type: EXPERIMENTAL
Intervention: Cytoreduction followed by hyperthermic intraperitoneal chemotherapy (HIPEC) and systemic chemotherapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Systemic chemotherapy alone (Control)
Number of subjects: 10
Study: 15955035

Group type: EXPERIMENTAL
Intervention: Patients with cluster headache (CH)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (individuals without CH)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Patients with CH
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Patients with CH with BMI > 25 kg/m(2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Patients with CH > 40 years old
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Patients with CH with BMI < 25 kg/m(2) and < 40 years old
Number of subjects: 37
Study: 12460092

Group type: COMPARATOR
Intervention: Usual ED evaluation strategy (n = 1260)
Number of subjects: 2475

Group type: EXPERIMENTAL
Intervention: Usual strategy supplemented with acute resting myocardial perfusion imaging (n = 1215)
Number of subjects: 2475
Study: 10048613

Group type: EXPERIMENTAL
Intervention: rHuEPO (300 IU/kg three times a week s.c.) and oral iron (ferrofumarate, 6 mg of iron/kg per day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: rHuEPO (300 IU/kg three times a week s.c.) and intramuscular iron (ferroxypolymaltose, once 12 mg of iron/kg weekly)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intramuscular iron (ferroxypolymaltose, once 12 mg of iron/kg weekly) without rHuEPO
Number of subjects: 41
Study: 7745510

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant
Number of subjects: 1540

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 1540
Study: 2105191

Group type: EXPERIMENTAL
Intervention: Pulse flow oxygen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Continuous flow oxygen
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cost savings from pulse flow oxygen
Number of subjects: 100
Study: 375461

Group type: EXPERIMENTAL
Intervention: Atropine methonitrate 2 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 microgram
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination of salbutamol and atropine methonitrate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31937341

Group type: COMPARATOR
Intervention: Bayesian adaptive designs with response adaptive randomisation (RAR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bayesian adaptive designs with arm dropping
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original trial designs
Number of subjects: 0
Study: 30651032

Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 5275

Group type: EXPERIMENTAL
Intervention: hs cardiac troponin I
Number of subjects: 5275

Group type: EXPERIMENTAL
Intervention: hs troponin T
Number of subjects: 5275

Group type: EXPERIMENTAL
Intervention: growth differentiation factor-15
Number of subjects: 5275
Study: 27354046

Group type: EXPERIMENTAL
Intervention: Intravenous procainamide (10 mg/kg/20 min)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Intravenous amiodarone (5 mg/kg/20 min)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Intravenous procainamide (10 mg/kg/20 min) in patients with structural heart disease
Number of subjects: 74

Group type: COMPARATOR
Intervention: Intravenous amiodarone (5 mg/kg/20 min) in patients with structural heart disease
Number of subjects: 74
Study: 26248345

Group type: EXPERIMENTAL
Intervention: Femtosecond laser group (40 eyes)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Manual group (40 eyes)
Number of subjects: 80
Study: 23758461

Group type: EXPERIMENTAL
Intervention: Removable Mandibular Retractor (RMR)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 33
Study: 21371499

Group type: EXPERIMENTAL
Intervention: Intervention group (n=149)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (n=148)
Number of subjects: 297
Study: 18356618

Group type: EXPERIMENTAL
Intervention: Home-based quadriceps exercise
Number of subjects: 121

Group type: COMPARATOR
Intervention: Nonsteroidal antiinflammatory drugs (NSAIDs)
Number of subjects: 121
Study: 17056973

Group type: EXPERIMENTAL
Intervention: D-NS (nerve stimulator guidance)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: P-NS (proximal block site with nerve stimulator guidance)
Number of subjects: 135

Group type: COMPARATOR
Intervention: D (distal block site without nerve stimulator guidance)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: D-NS
Number of subjects: 135

Group type: COMPARATOR
Intervention: D
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: P-NS
Number of subjects: 135
Study: 12881816

Group type: EXPERIMENTAL
Intervention: Stroke Impact Scale (SIS) version 3.0
Number of subjects: 696
Study: 10933082

Group type: EXPERIMENTAL
Intervention: Standard insecticide aerosol A
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Standard insecticide aerosol B
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Low irritant insecticide aerosol C
Number of subjects: 25

Group type: COMPARATOR
Intervention: Negative control aerosol
Number of subjects: 25
Study: 1600935

Group type: EXPERIMENTAL
Intervention: Caloreen supplementation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Starch (control)
Number of subjects: 64
Study: 2578352

Group type: EXPERIMENTAL
Intervention: Running under hot conditions (rectal temperature increase averaging 2.3 degrees C)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Running with additional cooling (rectal temperature rise reduced to an average of 1.0 degree C)
Number of subjects: 6
Study: 30874389

Group type: EXPERIMENTAL
Intervention: Thoracoscopic assisted reduction and percutaneous intramedullary nail fixation (trial group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional manual reduction and percutaneous intramedullary nail fixation (control group)
Number of subjects: 22
Study: 28404231

Group type: EXPERIMENTAL
Intervention: Negative Autobiographical Memory retrieval
Number of subjects: 12

Group type: COMPARATOR
Intervention: Neutral Autobiographical Memory retrieval
Number of subjects: 12
Study: 27595698

Group type: EXPERIMENTAL
Intervention: Breastfeeding with ZDV prophylaxis for 6 months
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Formula feeding with 4 weeks of ZDV
Number of subjects: 1200
Study: 24142460

Group type: EXPERIMENTAL
Intervention: Dexchlorpheniramine 4 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22643198

Group type: EXPERIMENTAL
Intervention: Health care benefits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health care benefits plus additional supports
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 20713293

Group type: EXPERIMENTAL
Intervention: In situ uterine repair (n = 2462)
Number of subjects: 4925

Group type: COMPARATOR
Intervention: Extra-abdominal uterine repair (n = 2463)
Number of subjects: 4925
Study: 18612151

Group type: EXPERIMENTAL
Intervention: Cetuximab plus chemotherapy (paclitaxel plus carboplatin)
Number of subjects: 229
Study: 15695472

Group type: EXPERIMENTAL
Intervention: Polarity Therapy (PT) treatments (1 or 2 treatments)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no PT treatments)
Number of subjects: 15
Study: 12406667

Group type: EXPERIMENTAL
Intervention: beclomethasone dipropionate bid (800 mcg) via jet nebulizer
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: beclomethasone dipropionate bid (800 mcg) via ultrasonic nebulizer
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 27
Study: 10427579

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist participation in daily ward rounds, soliciting information, and reviewing charts
Number of subjects: 1959

Group type: COMPARATOR
Intervention: Voluntary reports from physicians and nurses
Number of subjects: 1959
Study: 8908382

Group type: EXPERIMENTAL
Intervention: Fish oil (4.6 g n‐3 fatty acids/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 36
Study: 2057245

Group type: EXPERIMENTAL
Intervention: Survanta (100 mg of phospholipids/kg)
Number of subjects: 430
Study: 6405764

Group type: EXPERIMENTAL
Intervention: Tocainide
Number of subjects: 791

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 791
Study: 31416602

Group type: EXPERIMENTAL
Intervention: Metallic implants
Number of subjects: 84

Group type: COMPARATOR
Intervention: Biodegradable implants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 29157723

Group type: EXPERIMENTAL
Intervention: Defibrillation Testing (DT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No Defibrillation Testing (No DT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: HCM patients
Number of subjects: 52
Study: 26803913

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg/day, 250 mg twice daily) added to lipid-lowering therapy
Number of subjects: 860

Group type: COMPARATOR
Intervention: Lipid-lowering agents (control group)
Number of subjects: 860
Study: 24328637

Group type: EXPERIMENTAL
Intervention: Nicotine withdrawal syndrome in smokers with mental illness
Number of subjects: 10664

Group type: EXPERIMENTAL
Intervention: Anxiety-related symptoms as markers of withdrawal
Number of subjects: 10664

Group type: EXPERIMENTAL
Intervention: Motivation to quit smoking among smokers with mental illness
Number of subjects: 10664

Group type: EXPERIMENTAL
Intervention: Dependence and withdrawal effects on quit attempts
Number of subjects: 10664
Study: 22378733

Group type: EXPERIMENTAL
Intervention: D1 (flavanols only)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: D1-10 (flavanols and procyanidins)
Number of subjects: 12

Group type: COMPARATOR
Intervention: D2-10 (procyanidins only)
Number of subjects: 12
Study: 20489088

Group type: EXPERIMENTAL
Intervention: Sequential scanning mode
Number of subjects: 685

Group type: COMPARATOR
Intervention: Helical scanning mode
Number of subjects: 685
Study: 17548203

Group type: EXPERIMENTAL
Intervention: Cilostazol (100mg) twice daily orally
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 15322742

Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Teriparatide 40 microg
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Combined teriparatide treated groups
Number of subjects: 355
Study: 11999593

Group type: EXPERIMENTAL
Intervention: Sevoflurane in 100% oxygen
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sevoflurane with 50% nitrous oxide in oxygen
Number of subjects: 24
Study: 10464463

Group type: EXPERIMENTAL
Intervention: Ambulatory training program for osteoporotic patients (10 weeks duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 0
Study: 7828295

Group type: EXPERIMENTAL
Intervention: 50 mg losartan once daily
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 25 mg losartan once daily
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 2.5 mg losartan once daily
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 10 mg losartan once daily
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 50 mg losartan once daily after 12 weeks
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 25 mg losartan once daily after 12 weeks
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 2.5 mg losartan once daily after 12 weeks
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Active treatment (all doses)
Number of subjects: 154
Study: 2006662

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and triamterene
Number of subjects: 822

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 822
Study: 7049364

Group type: EXPERIMENTAL
Intervention: CCNU (130 mg/m2 every 6 weeks) + dexamethasone (4‐20 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CCNU (130 mg/m2 every 6 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VM‐26 (100 mg/m2) + CCNU (130 mg/m2 every 6 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procarbazine (3‐week courses of 150 mg/m2/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids only
Number of subjects: 0